GFACX
Price
$74.77
Change
+$0.15 (+0.20%)
Updated
Oct 17 closing price
Net Assets
336.91B
NVLIX
Price
$67.91
Change
+$0.27 (+0.40%)
Updated
Oct 17 closing price
Net Assets
868.68M
Interact to see
Advertisement

GFACX vs NVLIX

Header iconGFACX vs NVLIX Comparison
Open Charts GFACX vs NVLIXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.77
Change+$0.15 (+0.20%)
VolumeN/A
Net Assets336.91B
Nuveen Winslow Large-Cap Growth ESG I
Price$67.91
Change+$0.27 (+0.40%)
VolumeN/A
Net Assets868.68M
GFACX vs NVLIX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. NVLIX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and NVLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 337B vs. NVLIX (869M). GFACX (0.00) and NVLIX (0.00) have matching dividends . GFACX was incepted earlier than NVLIX: GFACX (25 years) vs NVLIX (16 years). GFACX (1.36) is less costly to investors than NVLIX (0.83). NVLIX is a more actively managed with annual turnover of: 56.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than NVLIX: GFACX (250) vs NVLIX (100000). GFACX annual gain was more profitable for investors over the last year : 9.41 vs. NVLIX (2.01). GFACX return over 5 years is better than : 30.67 vs. NVLIX (27.53).
GFACXNVLIXGFACX / NVLIX
Total Expense Ratio1.360.65209%
Annual Report Gross Expense Ratio1.360.83164%
Fund Existence25 years16 years-
Gain YTD17.26812.155142%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets337B869M38,780%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.412.01467%
Returns for 3 years64.7667.3596%
Returns for 5 years30.6727.53111%
Returns for 10 years80.6549.44163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CREV5.341.62
+43.36%
Carbon Revolution Public Limited
GIB87.100.02
+0.02%
CGI
ARMP3.40-0.09
-2.58%
Armata Pharmaceuticals
BLMN7.41-0.24
-3.14%
Bloomin' Brands
RXO17.24-0.60
-3.36%
RXO